Immunome Inc. (IMNM)

Typically moves ±6.21% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-11-10 APPROXIMATE

Across 22 earnings reports since Nov 17, 2020, Immunome Inc. (IMNM) has a clear post-earnings pattern. It moves ±6.21% on average after reporting and finishes higher 45.5% of the time. Its largest post-earnings gain was +23.03% (Mar 28, 2022) and its largest decline was -10.41% (Mar 28, 2024). The next earnings report is predicted for 2026-11-10 (approximate).

Earnings reactions

How IMNM moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±6.21%

Positive %

45.5%

Negative %

54.5%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 11, 2026	☽ POST	+6.61%	open_in_new
May 12, 2026	☽ POST	-1.99%	open_in_new
Mar 03, 2026	☽ POST	+4.55%	open_in_new
Nov 06, 2025	☽ POST	-1.68%	open_in_new
Aug 06, 2025	☽ POST	-5.64%	open_in_new
May 12, 2025	☽ POST	-0.38%	open_in_new
Mar 19, 2025	☽ POST	+1.05%	open_in_new
Nov 13, 2024	☽ POST	-3.88%	open_in_new
Aug 12, 2024	☽ POST	+7.04%	open_in_new
May 14, 2024	☀ PRE	-5.7%	open_in_new
Mar 28, 2024	☽ POST	-10.41%	open_in_new
Nov 09, 2023	☽ POST	-5.49%	open_in_new
Aug 09, 2023	☀ PRE	-2.09%	open_in_new
May 05, 2023	☀ PRE	-4.09%	open_in_new
Mar 16, 2023	☀ PRE	+9.24%	open_in_new
Nov 14, 2022	☀ PRE	+0.6%	open_in_new
Aug 05, 2022	☀ PRE	+17.41%	open_in_new
May 12, 2022	☀ PRE	+10.43%	open_in_new
Mar 28, 2022	☀ PRE	+23.03%	open_in_new
May 12, 2021	☀ PRE	-9.46%	open_in_new
Mar 25, 2021	☽ POST	+0.16%	open_in_new
Nov 17, 2020	☽ POST	-5.68%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±6.21%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 25 →

Funds holding

$535926786

Total value held

Buying

21 added · 4 reduced

Blackrock, Inc.

$186588376 +7.80%

State Street Corp

$116431104 +1.75%

Morgan Stanley

$51024322 -15.26%

Jpmorgan Chase & Co

$38989792 -33.45%

Goldman Sachs Group Inc

$32049642 +37.31%

SEC Filing Types

description SCHEDULE 13G/A

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
144	20260812	open_in_new SEC.gov
4	20260812	open_in_new SEC.gov
10-Q	20260811	open_in_new SEC.gov
8-K	20260811	open_in_new SEC.gov
S-8	20260811	open_in_new SEC.gov
4	20260810	open_in_new SEC.gov
144	20260806	open_in_new SEC.gov
4	20260806	open_in_new SEC.gov

Frequently asked about IMNM earnings

When does Immunome Inc. report earnings next? expand_more

Immunome Inc. (IMNM)'s next earnings date is approximate for 2026-11-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does IMNM stock move after earnings? expand_more

Over 22 reports, IMNM has moved an average of ±6.21% the session after earnings, closing higher 45.5% of the time.

What was IMNM's biggest post-earnings move? expand_more

IMNM's largest post-earnings gain on record was +23.03% on Mar 28, 2022, and its largest decline was -10.41% on Mar 28, 2024.

Where can I find Immunome Inc.'s SEC filings? expand_more

All of Immunome Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.